The purpose is to achieve tumour-specific delivery of a chemotherapy ‘drug activator’ in order to restrict cell kill by chemotherapy drugs to cancer tissues. Focus will be placed on obtaining a 'cancer specific nanoparticle’ to deliver these ‘drug activators’ to ensure that existing clinical drugs such as doxorubicin become more tumour selective.
Dr Suzanne Cutts, A/Prof Paul Pigram, Prof Geoff Pietersz, Dr Carleen Cullinane
Cancer Council Victoria Research Grant
La Trobe University
$100,000 in 2013 and $95,902 pa in 2014 & 2015, nil in 2016